Solid lipid nanoparticles as drug delivery systems

被引:213
作者
Manjunath, K [1 ]
Reddy, JS [1 ]
Venkateswarlu, V [1 ]
机构
[1] Kakatiya Univ, Novel Drug Delivery Syst Lab, Univ Coll Pharmaceut Sci, Warangal, Andhra Pradesh, India
来源
METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY | 2005年 / 27卷 / 02期
关键词
controlled drug release; formulation factors; solid lipid nanoparticles; targeted drug delivery;
D O I
10.1358/mf.2005.27.2.876286
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
For a decade, trials have been made to utilize solid lipid nanoparticles (SLNs) as alternative drug delivery systems to colloidal drag delivery systema such as lipid emulsions, liposomes, and polymeric nanoparticles. Various lipid matrices, sulfactants, and other excipients used formulation, preparation methods, sterilization and lyophilization of SLNs are discussed in this article. Entrapment efficiency of drug carrier and its effect on physical parameters, drug release, and release mechanisms of various compositions are reviewed and discussed. Important points in characterization and stability of SLNs are outlined. Various in vitro studies carried out by different research groups are mentioned in addition to in vivo evaluation. Exploitation potential of SLNs to administer by various routes of administration are covered. passive and active drug targeting using SLNs are presented. (c) 2005 Prous Science. All rights reserved.
引用
收藏
页码:127 / 144
页数:18
相关论文
共 107 条
  • [1] Influence of spin probe structure on its distribution in SLN dispersions
    Ahlin, P
    Kristl, J
    Sentjurc, M
    Strancar, J
    Pecar, S
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2000, 196 (02) : 241 - 244
  • [2] Peptide-loaded solid lipid nanoparticles (SLN): Influence of production parameters
    Almeida, AJ
    Runge, S
    Muller, RH
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1997, 149 (02) : 255 - 265
  • [3] STEALTH ME.PEG-PLA NANOPARTICLES AVOID UPTAKE BY THE MONONUCLEAR PHAGOCYTES SYSTEM
    BAZILE, D
    PRUDHOMME, C
    BASSOULLET, MT
    MARLARD, M
    SPENLEHAUER, G
    VEILLARD, M
    [J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 1995, 84 (04) : 493 - 498
  • [4] INFLUENCE OF PROPYLENE-GLYCOL AS COSOLVENT ON MECHANISMS OF DRUG TRANSPORT FROM HYDROGELS
    BENDAS, B
    SCHMALFUSS, U
    NEUBERT, R
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1995, 116 (01) : 19 - 30
  • [5] Phagocytic uptake of fluorescent stealth and non-stealth solid lipid nanoparticles
    Bocca, C
    Caputo, O
    Cavalli, RB
    Gabriel, L
    Miglietta, A
    Gasco, MR
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1998, 175 (02) : 185 - 193
  • [6] Bummer PM, 2004, CRIT REV THER DRUG, V21, P1
  • [7] Sterilization and freeze-drying of drug-free and drug-loaded solid lipid nanoparticles
    Cavalli, R
    Caputo, O
    Carlotti, ME
    Trotta, M
    Scarnecchia, C
    Gasco, MR
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1997, 148 (01) : 47 - 54
  • [8] Duodenal administration of solid lipid nanoparticles loaded with different percentages of tobramycin
    Cavalli, R
    Bargon, A
    Podio, V
    Munton, E
    Zara, CP
    Gasco, MR
    [J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 2003, 92 (05) : 1085 - 1094
  • [9] Solid lipid nanoparticles (SLN) as ocular delivery system for tobramycin
    Cavalli, R
    Gasco, MR
    Chetoni, P
    Burgalassi, S
    Saettone, MF
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2002, 238 (1-2) : 241 - 245
  • [10] PREPARATION AND EVALUATION IN-VITRO OF COLLOIDAL LIPOSPHERES CONTAINING PILOCARPINE AS ION-PAIR
    CAVALLI, R
    MOREL, S
    GASCO, MR
    CHETONI, P
    SAETTONE, MF
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1995, 117 (02) : 243 - 246